Quent Capital’s Radiopharm Theranostics RADX Stock Holding History
Bought
Maintained
Sold
Other funds holding RADX
Quent Capital's RADX Position: Q3 2026 in Review
Quent Capital opened a new position in Radiopharm Theranostics (RADX) in Q3 2026: 229 shares worth $371. The stake represents ﹤0.01% of the portfolio and ranks #1618 among its holdings.
8 funds tracked by Wall St. Rank hold RADX as of Q3 2026.
- Quent Capital held 229 shares of Radiopharm Theranostics worth $371 as of Q3 2026.
- Radiopharm Theranostics was a new Quent Capital position in Q3 2026.
- Radiopharm Theranostics made up ﹤0.01% of Quent Capital's portfolio in Q3 2026, its #1618 holding.
- 8 funds tracked by Wall St. Rank held Radiopharm Theranostics as of Q3 2026.
Based on Quent Capital's 13F filing for Q3 2026, filed 9 Nov 2026.